These medications do not have the same safety brakes as GLP-1s, and the added insulin-sensitizing effect of inositol could push your blood sugar into a dangerous range
However, the panel, chaired by Stefanie Schle and comprising first examiner Josep Gimenez Miralles and second examiner Heidi van den Bulcke, came to a different conclusion and upheld EP 111
Like its lower-dose counterparts, it activates three powerful metabolic pathways GLP-1, GIP, and glucagon receptors but offers superior longevity per vial, ideal for long-term protocols
In patients with CKD, liraglutide, semaglutide, and dulaglutide do not require dose adjustment in mild to moderate renal impairment
This synergistic combination is why it outperformed earlier GLP-1 monotherapies like semaglutide